Income statement
USD
Annual
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2M | 2M | 4M | 5M | 8M |
| Gross Profit | 1M | 331K | 911K | 2M | 3M |
| Operating Income | -3M | -4M | -4M | -22M | -12M |
| EBITDA | -3M | -4M | -4M | -20M | -6M |
| Net Income | -6M | -4M | -4M | -22M | -9M |
| EPS (Diluted) | — | — | — | — | — |
Financial Services
Live Price
Offline$1.50
-9.09% today
1Y Change
-51.34%
Window
Jun 23, 2025 → Jun 16, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
TaoWeave, Inc. (TWAV) is a Financial Services stock with a market cap of $10.00M and listed on NASDAQ. The stock last traded around $1.50 and down 51.3% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of +2.5%, EPS growth of +82.4%, a dividend yield of 0.0%. What stands out right now is revenue +2.5%, EPS +82.4%, free cash flow +11.5% with operating margin -121.5% and ROIC -42.1%. Valuation is more restrained than many high-expectation growth names at price/sales 2.4. Stock Foundry combines TWAV price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TWAV
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TWAV Max Drawdown
-87.41%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TWAV and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$7.7M
+41.3% YoY
FY Net Income
-$9.1M
+58.7% YoY
Free Cash Flow
-$7.8M
-30.9% YoY
Revenue Growth
+2.5%
EPS Growth
+82.4%
Gross Margin
41.6%
Net Margin
-260.8%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2M | 2M | 4M | 5M | 8M |
| Gross Profit | 1M | 331K | 911K | 2M | 3M |
| Operating Income | -3M | -4M | -4M | -22M | -12M |
| EBITDA | -3M | -4M | -4M | -20M | -6M |
| Net Income | -6M | -4M | -4M | -22M | -9M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2M | 5M | 5M | 3M | 9M |
| Total Assets | 8M | 5M | 7M | 6M | 29M |
| Total Liabilities | 1M | 1M | 1M | 2M | 3M |
| Shareholder Equity | 7M | 4M | 6M | 4M | 25M |
| Total Debt | 0 | 0 | 17K | 236K | 728K |
| Net Debt | -2M | -5M | -6M | -3M | -8M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
8M
-30.3% YoY
Capital Expenditures
50K
-354.5% YoY
Free Cash Flow
8M
-30.9% YoY
Key ratios
Gross Margin
41.6%
Operating Margin
-121.5%
Net Margin
-260.8%
ROE
-80.8%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.